N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide

C49H53N17O7 — CID 168972087

IUPACN-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide
SMILESCN1CCCC12CN(c1nc3nc(NCCO)oc3cc1C(=O)Nc1cccc(-c3cnn(COCCNc4nc5nc(N6CC(O)(C7CC7)C6)c(C(=O)Nc6cccc(-c7cnn(C)c7)n6)cc5o4)c3)n1)C2
InChIInChI=1S/C49H53N17O7/c1-62-15-5-12-48(62)24-64(25-48)42-32(18-36-40(58-42)60-46(72-36)50-13-16-67)44(68)57-39-9-4-7-35(55-39)30-21-53-66(23-30)28-71-17-14-51-47-61-41-37(73-47)19-33(43(59-41)65-26-49(70,27-65)31-10-11-31)45(69)56-38-8-3-6-34(54-38)29-20-52-63(2)22-29/h3-4,6-9,18-23,31,67,70H,5,10-17,24-28H2,1-2H3,(H,50,58,60)(H,51,59,61)(H,54,56,69)(H,55,57,68)
InChIKeyPTMXWMZPDNRTHX-UHFFFAOYSA-N
MW992.07 g/mol
LogP4.05
Rot. Bonds18

About N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide

N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide (PubChem CID 168972087) has the molecular formula C49H53N17O7 and a molecular weight of 992.07 g/mol. Its IUPAC name is N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide.

Molecular Properties

Compound NameN-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide
PubChem CID168972087
Molecular FormulaC49H53N17O7
Molecular Weight992.07 g/mol
Exact Mass991.43
IUPAC NameN-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide
SMILESCN1CCCC12CN(c1nc3nc(NCCO)oc3cc1C(=O)Nc1cccc(-c3cnn(COCCNc4nc5nc(N6CC(O)(C7CC7)C6)c(C(=O)Nc6cccc(-c7cnn(C)c7)n6)cc5o4)c3)n1)C2
InChIInChI=1S/C49H53N17O7/c1-62-15-5-12-48(62)24-64(25-48)42-32(18-36-40(58-42)60-46(72-36)50-13-16-67)44(68)57-39-9-4-7-35(55-39)30-21-53-66(23-30)28-71-17-14-51-47-61-41-37(73-47)19-33(43(59-41)65-26-49(70,27-65)31-10-11-31)45(69)56-38-8-3-6-34(54-38)29-20-52-63(2)22-29/h3-4,6-9,18-23,31,67,70H,5,10-17,24-28H2,1-2H3,(H,50,58,60)(H,51,59,61)(H,54,56,69)(H,55,57,68)
InChIKeyPTMXWMZPDNRTHX-UHFFFAOYSA-N
XLogP4.05
TPSA280.93 Ų
H-Bond Donors6
H-Bond Acceptors22
Rotatable Bonds18
Heavy Atoms73
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500992.07
LogP ≤ 54.05
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide?
The IUPAC name of N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide (CID 168972087) is N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide.
What is the SMILES notation for N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide?
The canonical SMILES for N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide is CN1CCCC12CN(c1nc3nc(NCCO)oc3cc1C(=O)Nc1cccc(-c3cnn(COCCNc4nc5nc(N6CC(O)(C7CC7)C6)c(C(=O)Nc6cccc(-c7cnn(C)c7)n6)cc5o4)c3)n1)C2.
What is the InChIKey of N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide?
The InChIKey is PTMXWMZPDNRTHX-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H53N17O7/c1-62-15-5-12-48(62)24-64(25-48)42-32(18-36-40(58-42)60-46(72-36)50-13-16-67)44(68)57-39-9-4-7-35(55-39)30-21-53-66(23-30)28-71-17-14-51-47-61-41-37(73-47)19-33(43(59-41)65-26-49(70,27-65)31-10-11-31)45(69)56-38-8-3-6-34(54-38)29-20-52-63(2)22-29/h3-4,6-9,18-23,31,67,70H,5,10-17,24-28H2,1-2H3,(H,50,58,60)(H,51,59,61)(H,54,56,69)(H,55,57,68).
What are the key properties of N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide?
N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide has a molecular weight of 992.07 g/mol, XLogP of 4.05, 18 rotatable bonds, 6 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[1-[2-[[5-(3-cyclopropyl-3-hydroxyazetidin-1-yl)-6-[[6-(1-methylpyrazol-4-yl)-2-pyridinyl]carbamoyl]-[1,3]oxazolo[4,5-b]pyridin-2-yl]amino]ethoxymethyl]pyrazol-4-yl]-2-pyridinyl]-2-(2-hydroxyethylamino)-5-(5-methyl-2,5-diazaspiro[3.4]octan-2-yl)-[1,3]oxazolo[4,5-b]pyridine-6-carboxamide is sourced from PubChem (CID 168972087), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).